{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19766199", "DateCompleted": {"Year": "2010", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "09", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.nlm.2009.09.006"], "Journal": {"ISSN": "1095-9564", "JournalIssue": {"Volume": "93", "Issue": "2", "PubDate": {"Year": "2010", "Month": "Feb"}}, "Title": "Neurobiology of learning and memory", "ISOAbbreviation": "Neurobiol Learn Mem"}, "ArticleTitle": "Chronic administration of troxerutin protects mouse brain against D-galactose-induced impairment of cholinergic system.", "Pagination": {"StartPage": "157", "EndPage": "164", "MedlinePgn": "157-64"}, "Abstract": {"AbstractText": ["Previous evidence showed that administration of d-galactose (d-gal) increased ROS production and resulted in impairment of cholinergic system. Troxerutin, a natural bioflavonoid, has been reported to have many benefits and medicinal properties. In this study, we evaluated the protective effect of troxerutin against d-gal-induced impairment of cholinergic system, and explored the potential mechanism of its action. Our results displayed that troxerutin administration significantly improved behavioral performance of d-gal-treated mice in step-through test and morris water maze task. One of the potential mechanisms of this action was decreased AGEs, ROS and protein carbonyl levels in the basal forebrain, hippocampus and front cortex of d-gal-treated mice. Furthermore, our results also showed that troxerutin significantly inhibited cholinesterase (AchE) activity, increased the expression of nicotinic acetylcholine receptor alpha 7 (nAchRalpha7) and enhanced interactions between nAchRalpha7 and either postsynaptic density protein 95 (PSD95) or N-methyl-d-aspartate receptors subunit 1 (NMDAR1) in the basal forebrain, hippocampus and front cortex of d-gal-treated mice, which could help restore impairment of brain function."], "CopyrightInformation": "Crown Copyright 2009. Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Xuzhou Normal University, Xuzhou 221116, Jiangsu Province, PR China."}], "Identifier": [], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hu", "ForeName": "Bin", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheng", "ForeName": "Wei", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Zi-Feng", "Initials": "ZF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ye", "ForeName": "Qin", "Initials": "Q"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fan", "ForeName": "Shao-Hua", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shan", "ForeName": "Qun", "Initials": "Q"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Yong-Jian", "Initials": "YJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Neurobiol Learn Mem", "NlmUniqueID": "9508166", "ISSNLinking": "1074-7427"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chrna7 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Disks Large Homolog 4 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Dlg4 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycation End Products, Advanced"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydroxyethylrutoside"}, {"RegistryNumber": "0", "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NMDA receptor A1"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, N-Methyl-D-Aspartate"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Nicotinic"}, {"RegistryNumber": "0", "NameOfSubstance": "alpha7 Nicotinic Acetylcholine Receptor"}, {"RegistryNumber": "7Y4N11PXO8", "NameOfSubstance": "troxerutin"}, {"RegistryNumber": "EC 2.7.4.8", "NameOfSubstance": "Guanylate Kinases"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "X2RN3Q8DNE", "NameOfSubstance": "Galactose"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Avoidance Learning"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Disks Large Homolog 4 Protein"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Frontal Lobe"}, {"QualifierName": ["metabolism", "toxicity"], "DescriptorName": "Galactose"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glycation End Products, Advanced"}, {"QualifierName": [], "DescriptorName": "Guanylate Kinases"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Hippocampus"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "pharmacology"], "DescriptorName": "Hydroxyethylrutoside"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intracellular Signaling Peptides and Proteins"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": ["metabolism"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Neuropsychological Tests"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Prosencephalon"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Carbonylation"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, N-Methyl-D-Aspartate"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Nicotinic"}, {"QualifierName": [], "DescriptorName": "alpha7 Nicotinic Acetylcholine Receptor"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "8", "Day": "3"}, {"Year": "2009", "Month": "9", "Day": "9"}, {"Year": "2009", "Month": "9", "Day": "12"}, {"Year": "2009", "Month": "9", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2009", "Month": "9", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19766199", "10.1016/j.nlm.2009.09.006", "S1074-7427(09)00196-8"]}}], "PubmedBookArticle": []}